KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Buildings (2016 - 2025)

Historic Buildings for Bristol Myers Squibb (BMY) over the last 12 years, with Q4 2025 value amounting to $7.3 billion.

  • Bristol Myers Squibb's Buildings rose 1046.95% to $7.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 billion, marking a year-over-year increase of 1046.95%. This contributed to the annual value of $7.3 billion for FY2025, which is 1046.95% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Buildings of $7.3 billion as of Q4 2025, which was up 1046.95% from $7.1 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Buildings peaked at $7.3 billion during Q4 2025, and registered a low of $5.6 billion during Q1 2021.
  • Over the past 5 years, Bristol Myers Squibb's median Buildings value was $6.2 billion (recorded in 2023), while the average stood at $6.3 billion.
  • Its Buildings has fluctuated over the past 5 years, first crashed by 403.56% in 2021, then soared by 1046.95% in 2025.
  • Bristol Myers Squibb's Buildings (Quarter) stood at $5.9 billion in 2021, then increased by 0.39% to $5.9 billion in 2022, then increased by 9.71% to $6.5 billion in 2023, then increased by 1.32% to $6.6 billion in 2024, then rose by 10.47% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q4 2025, $7.1 billion for Q3 2025, and $6.9 billion during Q2 2025.